196 related articles for article (PubMed ID: 26496210)
1. Paricalcitol, Microvascular and Endothelial Function in Non-Diabetic Chronic Kidney Disease: A Randomized Trial.
Lundwall K; Jörneskog G; Jacobson SH; Spaak J
Am J Nephrol; 2015; 42(4):265-73. PubMed ID: 26496210
[TBL] [Abstract][Full Text] [Related]
2. Serum phosphate modifies the vascular response to vitamin D receptor activation in chronic kidney disease (CKD) patients.
Zoccali C; Torino C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Ghiadoni L; Thadhani R; Tripepi G; Mallamaci F
Nutr Metab Cardiovasc Dis; 2016 Jul; 26(7):581-589. PubMed ID: 27113290
[TBL] [Abstract][Full Text] [Related]
3. Paricalcitol and endothelial function in chronic kidney disease trial.
Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F
Hypertension; 2014 Nov; 64(5):1005-11. PubMed ID: 25259743
[TBL] [Abstract][Full Text] [Related]
4. Effect of paricalcitol on endothelial function and inflammation in type 2 diabetes and chronic kidney disease.
Thethi TK; Bajwa MA; Ghanim H; Jo C; Weir M; Goldfine AB; Umpierrez G; Desouza C; Dandona P; Fang-Hollingsworth Y; Raghavan V; Fonseca VA
J Diabetes Complications; 2015 Apr; 29(3):433-7. PubMed ID: 25633573
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral paricalcitol therapy on arterial stiffness and osteopontin in hypertensive patients with chronic kidney disease and secondary hyperparathyroidism.
Giakoumis M; Tsioufis C; Dimitriadis K; Sonikian M; Kasiakogias A; Andrikou E; Kalos T; Konstantinidis D; Filis K; Petras D; Tousoulis D
Hellenic J Cardiol; 2019; 60(2):108-113. PubMed ID: 29305902
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D receptor activation by paricalcitol and insulin resistance in CKD.
Spoto B; Pizzini P; Cutrupi S; Tripepi G; Curatola G; Mallamaci F; Zoccali C
Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):291-297. PubMed ID: 29307660
[TBL] [Abstract][Full Text] [Related]
7. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial.
Fishbane S; Chittineni H; Packman M; Dutka P; Ali N; Durie N
Am J Kidney Dis; 2009 Oct; 54(4):647-52. PubMed ID: 19596163
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D receptor activation reduces inflammatory cytokines and plasma MicroRNAs in moderate chronic kidney disease - a randomized trial.
Mansouri L; Lundwall K; Moshfegh A; Jacobson SH; Lundahl J; Spaak J
BMC Nephrol; 2017 May; 18(1):161. PubMed ID: 28511692
[TBL] [Abstract][Full Text] [Related]
9. Effects of aerobic exercise on vascular function in nondialysis chronic kidney disease: a randomized controlled trial.
Kirkman DL; Ramick MG; Muth BJ; Stock JM; Pohlig RT; Townsend RR; Edwards DG
Am J Physiol Renal Physiol; 2019 May; 316(5):F898-F905. PubMed ID: 30810061
[TBL] [Abstract][Full Text] [Related]
10. Ergocalciferol and microcirculatory function in chronic kidney disease and concomitant vitamin d deficiency: an exploratory, double blind, randomised controlled trial.
Dreyer G; Tucker AT; Harwood SM; Pearse RM; Raftery MJ; Yaqoob MM
PLoS One; 2014; 9(7):e99461. PubMed ID: 25006678
[TBL] [Abstract][Full Text] [Related]
11. A randomized control trial to assess the impact of vitamin D supplementation compared to placebo on vascular stiffness in chronic kidney disease patients.
Levin A; Perry T; De Zoysa P; Sigrist MK; Humphries K; Tang M; Djurdjev O
BMC Cardiovasc Disord; 2014 Nov; 14():156. PubMed ID: 25381032
[TBL] [Abstract][Full Text] [Related]
12. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
Cozzolino M; Brancaccio D
Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
[TBL] [Abstract][Full Text] [Related]
13. Tetrahydrobiopterin lowers muscle sympathetic nerve activity and improves augmentation index in patients with chronic kidney disease.
Park J; Liao P; Sher S; Lyles RH; Deveaux DD; Quyyumi AA
Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(3):R208-18. PubMed ID: 25477424
[TBL] [Abstract][Full Text] [Related]
14. Active vitamin D treatment in CKD patients raises serum sclerostin and this effect is modified by circulating pentosidine levels.
Torino C; Pizzini P; Cutrupi S; Tripepi G; Mallamaci F; Thadhani R; Zoccali C
Nutr Metab Cardiovasc Dis; 2017 Mar; 27(3):260-266. PubMed ID: 28017524
[TBL] [Abstract][Full Text] [Related]
15. The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection.
Duplancic D; Cesarik M; Poljak NK; Radman M; Kovacic V; Radic J; Rogosic V
Clin Interv Aging; 2013; 8():149-56. PubMed ID: 23430986
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial.
D'arrigo G; Pizzini P; Cutrupi S; Tripepi R; Tripepi G; Mallamaci F; Zoccali C
Nephrol Dial Transplant; 2019 May; 34(5):819-824. PubMed ID: 29668990
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of dynamic renal resistive index (DRIN) for renal outcome in type 2 diabetes and essential hypertension: a prospective study.
Bruno RM; Salvati A; Barzacchi M; Raimo K; Taddei S; Ghiadoni L; Solini A
Cardiovasc Diabetol; 2015 May; 14():63. PubMed ID: 25994303
[TBL] [Abstract][Full Text] [Related]
18. Randomized Controlled Trial for the Effect of Vitamin D Supplementation on Vascular Stiffness in CKD.
Levin A; Tang M; Perry T; Zalunardo N; Beaulieu M; Dubland JA; Zerr K; Djurdjev O
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1447-1460. PubMed ID: 28550081
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of vitamin D receptor activators on aortic calcification and pulse wave velocity in uraemic rats.
Noonan W; Koch K; Nakane M; Ma J; Dixon D; Bolin A; Reinhart G
Nephrol Dial Transplant; 2008 Dec; 23(12):3824-30. PubMed ID: 18644798
[TBL] [Abstract][Full Text] [Related]
20. Microvascular endothelial dysfunction is associated with albuminuria and CKD in older adults.
Seliger SL; Salimi S; Pierre V; Giffuni J; Katzel L; Parsa A
BMC Nephrol; 2016 Jul; 17(1):82. PubMed ID: 27412615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
